Charlie's Holdings, Inc.
Close on Oct 19, 2026
- Market cap
- $31.05M
- P/E (TTM)
- –
- Dividend yield
- –
About Charlie's
Medicinal Chemicals & Botanical Products, SIC 2833
Charlie’s Holdings, Inc. formulates, markets, and distributes alternative alkaloid non-nicotine vapor products, electronic nicotine delivery systems, and non-combustible e-liquids. Its products include synthetic nicotine and tobacco-derived disposable devices under the Pacha and PACHAMAMA brands, refillable e-liquids, nicotine salt formulations, and zero-nicotine Metatine alkaloid disposables under the SBX line. The company also develops product access and compliance technologies, integrating Bluetooth-enabled age-verification systems into devices. It does not sell directly to consumers online, distributing products instead through specialty retailers, convenience stores, liquor stores, gas stations, direct sales, and wholesale distributors.
The company operates filling operations in Huntington Beach, California, and utilizes ISO Class 7 certified contract manufacturing facilities in the United States alongside partner manufacturing in China. Products are distributed across the United States and within selected international markets through more than 3,000 specialty retailers. Charlie’s Holdings, Inc. maintains its corporate headquarters in Costa Mesa, California.
Summary of the business section of Charlie's's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Charlie's Holdings, Inc.
- Founded
- 2001
- Headquarters
- Costa Mesa, CA
- Address
- 1007 Brioso Dr. 92627
- Phone
- (949) 570-0691
- Website
- charlieschalkdust.com
- Employees
- 35, Dec 31, 2025
- Industry
- Medicinal Chemicals & Botanical Products
- Incorporated in
- Nevada
- Fiscal year ends
- December 31
- Auditor
- Urish Popeck & Co., LLC, Pittsburgh, Pennsylvania
Stock & identifiers
- Ticker
- CHUC
- Exchange
- OTC
- IPO date
- Jan 2, 2013
- Shares outstanding
- 281M, Aug 17, 2026
- Public float
- $17.90M, Jun 30, 2025
- Filer category
- Non-accelerated filer<br>Smaller reporting company
- Stock splits
- 1-for-100 reverse, Aug 16, 2021; 1-for-100 reverse, Jan 22, 2013
- SEC CIK
- 1134765
- CUSIP
- 16077A200
- ISIN
- US16077A2006
- EIN
- 84-1575085
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Henry Sicignano Iii | President | 10,450,001 |
| Matthew P. Montesano | Chief Financial Officer | 3,325,409 |
| Ryan Stump | Chief Operating Officer | 29,901,755 |
| Scot Cohen | Director | 2,212,404 |
| Michael D. King | Director | 6,950,001 |
| Edward Carmines | Director | 2,456,481 |
| Jeffrey G. Fox | Director | 1,650,000 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 Henry Sicignano III | $277.67K | $451.57K | $211.13K | $279 | – |
| FY2024 Former PEO | $0 | $0 | $188.13K | $50 | – |
| FY2024 Henry Sicignano III | $242.82K | $201.17K | $188.13K | $50 | – |
| FY2023 Former PEO | $0 | $0 | $242.00K | $106 | – |
| FY2023 Henry Sicignano III | $323.00K | $373.00K | $242.00K | $106 | – |
| FY2022 | $270.00K | $242.00K | $376.00K | $39 | – |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Employees
Headcount reported in annual reports
“We had 35 full-time employees as of March 31, 2026.”
Corporate history
Events identified from SEC filings